Over 70 international experts from academia, industry and biotech will address issues to learn about the latest trends and explore hands-on approaches to tech transfer and open innovation in the field of Life Sciences, by sharing their experience and knowledge.
The last confirmed speakers are:
- Ward Capoen, Senior Analyst, V-Bio Ventures [BE]
- Barbara Domayne-Hayman, CBO, Puridify [UK]
- Douglas Dundonald, Founder and Director, Anglo Scientific [UK]
- Hakan Goker, Senior Investment Director, Merck Ventures [NL]
- Frank Hensel, Senior Investment Manager, High-Tech Gründerfonds [DE]
- Paul Hermant, Corporate & Finance Partner, Bird & Bird [BE]
- Klaus Mendla, Business Development and Licensing, Boehringer Ingelheim [DE]
- Miguel Mulet, Director Strategy and New Projects, TiGenix [BE]
- Pascal Neuville, CEO, Domain Therapeutics [FR]
- Michael Nowak, Owner, Nowak Ventures [US]
- Gérard-Marie Papierok, Honorary Chairman of Eurobiomed Competitive Cluster Public Research and Clusters Partnership Manager, Virbac [FR]
- James Peyer, Managing Partner, Apollo Ventures [US]
- Tamar Raz, CEO, Hadasit Medical Research Services & Development [IL]
- Christian Tidona, Director and Founder, BioMed X [DE]
- Wendy White, Senior VP, Dohmen Life Science Services [US]
|
